Early data of phase III study in patients (pts) with stage IV non-small-cell lung cancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone

S. Novello; C. Barone; R. Buosi; G. Michetti; S. Barbera; M. Fioretti; A. Masotti; L. Garetto; P. Bruzzi; G. V. Scagliotti

doi:10.1200/jco.2004.22.90140.7069

Early data of phase III study in patients (pts) with stage IV non-small-cell lung cancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7069 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7069-7069

Author(s):

S. Novello ◽

C. Barone ◽

R. Buosi ◽

G. Michetti ◽

S. Barbera ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Early Data ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Early data of phase III study in patients (pts) with stage IV non-small-cell lung cancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7069 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7069-7069

Author(s):

S. Novello ◽

C. Barone ◽

R. Buosi ◽

G. Michetti ◽

S. Barbera ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Early Data ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Annals of Oncology ◽

10.1093/annonc/mdm061 ◽

2007 ◽

Vol 18 (5) ◽

pp. 903-908 ◽

Cited By ~ 14

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

R. Buosi ◽

A. Masotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

3073 Exploratory analysis of frontline therapies in REVEL: A randomized phase III study of ramucirumab (RAM) plus docetaxel (DOC) versus DOC for the treatment of stage IV non-small-cell lung cancer (NSCLC) after disease progression on platinum-based therapy

European Journal of Cancer ◽

10.1016/s0959-8049(16)31714-2 ◽

2015 ◽

Vol 51 ◽

pp. S621

Author(s):

E.B. Garon ◽

G.V. Scagliotti ◽

O. Gautschi ◽

M. Reck ◽

M. Thomas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Disease Progression ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Exploratory Analysis ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Phase III study in stage IV non-small-cell lung cancer (NSCLC) patients (pts) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7051 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7051-7051

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

A. Masotti ◽

R. Buosi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Nsclc Patients

Download Full-text

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

Frontiers in Oncology ◽

10.3389/fonc.2020.578756 ◽

2020 ◽

Vol 10 ◽

Cited By ~ 1

Author(s):

Jonathan W. Goldman ◽

Julien Mazieres ◽

Fabrice Barlesi ◽

Konstantin H. Dragnev ◽

Marianna Koczywas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kras Mutation ◽

Stage Iv ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) in advanced (stage IIIB and stage IV) non-small cell lung cancer (NSCLC). A multicenter phase III study

European Journal of Cancer ◽

10.1016/s0959-8049(99)81409-9 ◽

1999 ◽

Vol 35 ◽

pp. S249-S250 ◽

Cited By ~ 3

Author(s):

H. Kunitoh ◽

N. Saijo ◽

K. Nagao ◽

Y. Ohashi ◽

H. Niitani

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase Iii ◽

Advanced Stage ◽

Small Cell Lung ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70422-6 ◽

2007 ◽

Vol 2007 ◽

pp. 206-207

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Oral Topotecan

Download Full-text

Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen

Pneumologie ◽

10.1055/s-2008-1074239 ◽

2008 ◽

Vol 62 (S 2) ◽

Author(s):

J von Pawel ◽

M Reck ◽

R Ramlau ◽

J Jassem ◽

P Zatloukal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120004.586903 ◽

2008 ◽

Author(s):

Daniel Vorobiof ◽

Keo Tabane

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Advanced Stage ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13649956.15438060 ◽

2012 ◽

Author(s):

Paul Van Schil

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text